Physician profile
Justin D Moellinger
NPI 1134290984
$10,331.08
in general payments reported to CMS, 2019-2025
48 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,521 · 2020: $766 · 2021: $1,312 · 2022: $1,752 · 2023: $1,376 · 2024: $1,716 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,979.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,124.27 | 2019-2022 | |
| Abbvie INC. | $1,627.16 | 2021-2025 | |
| Integra Lifesciences Corporation | $770.16 | 2019-2024 | Integra, Omnigraft, Surgimend |
| Smith+Nephew, INC. | $636.78 | 2019-2025 | Grafix Pl, Oasis, Renasys Go V2 Home |
| C. R. Bard, INC. & Subsidiaries | $628.92 | 2019 | |
| Innovation Technologies INC | $543.76 | 2021-2024 | Irrisept |
| Ethicon US, LLC | $431.31 | 2019-2025 | Echelon; Endopath, Vistaseal, Echelon Flex |
| Davol INC. | $404.66 | 2019-2024 | Phasix Mesh |
| Organogenesis INC. | $253.10 | 2019-2022 | |
| Kerecis Limited | $242.05 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Cumberland Pharmaceuticals, INC. | $236.39 | 2019-2023 | Vibativ |
| Paratek Pharmaceuticals, INC. | $192.95 | 2019-2022 | |
| Avita Medical Americas, LLC | $159.49 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Conmed Corporation | $156.25 | 2019-2023 | Airseal, Conmed Specimen Retrieval |
| Medtronic, INC. | $139.42 | 2023-2025 | Maxtack, Sonicision, Reliatack |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $139.23 | 2019 | |
| Medline Industries LP | $139.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $135.41 | 2022-2023 | Seglentis |
| Osiris Therapeutics INC. | $135.13 | 2019 | |
| Medela LLC | $129.50 | 2022-2024 | Invia Motion Endure |
| Acell, INC. | $117.84 | 2020 | |
| Acera Surgical, INC. | $84.52 | 2019-2020 | |
| Mimedx Group, INC. | $75.81 | 2025 | |
| Solventum Corporation | $75.59 | 2024-2025 | Activ.A.C., V.A.C.Ulta, Activ.A.C. Ion Progress |
| Braintree Laboratories, INC. | $71.58 | 2023-2024 | Sutab, Suflave |
| Takeda Pharmaceuticals U.S.A., INC. | $68.09 | 2021-2022 | |
| Biocomposites INC | $64.21 | 2021-2025 | Stimulan |
| Urgo Medical North America, LLC | $55.14 | 2024-2025 | Urgoclean Ag |
| Hologic Sales and Service, LLC | $49.15 | 2023-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Boston Scientific Corporation | $44.23 | 2025 | Spyglass Discover |
| Melinta Therapeutics, LLC | $42.58 | 2022 | |
| Tela Bio, INC. | $39.33 | 2020 | |
| Polynovo North America LLC | $38.68 | 2022 | |
| Tei Biosciences INC | $28.69 | 2019 | |
| Coloplast Corp | $27.70 | 2022-2023 | Speedicath |
| Cardinal Health 200 LLC | $23.43 | 2019 | |
| Asensus Surgical, INC. | $22.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.70 | 2025 | |
| Next Science LLC | $19.98 | 2022 | |
| Innocoll Pharmaceuticals Limited | $18.53 | 2022 | |
| Teleflex LLC | $17.67 | 2024 | Deknatel |
| Baudax Bio INC. | $17.61 | 2020 | |
| Bioventus LLC | $16.33 | 2022 | |
| Depuy Synthes Sales INC. | $15.92 | 2022 | |
| Misonix INC | $14.30 | 2019 | |
| Intra-Sana Laboratories | $13.69 | 2021 | |
| Shire North American Group INC | $12.11 | 2019 | |
| Thd America, INC. | $9.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Moellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.